Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Details
Secondary document(s)
Download: paper_II_Appendix_A.pdf (814.73 [Ko])
State: Public
Version: Supplementary document
License: Not specified
State: Public
Version: Supplementary document
License: Not specified
Download: paper_II_Appendix_B.pdf (132.87 [Ko])
State: Public
Version: Supplementary document
License: Not specified
State: Public
Version: Supplementary document
License: Not specified
Download: paper_II_RATING_score_sheet.pdf (676.46 [Ko])
State: Public
Version: Supplementary document
License: Not specified
State: Public
Version: Supplementary document
License: Not specified
Serval ID
serval:BIB_49E1CA979679
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Journal
Medical physics
ISSN
2473-4209 (Electronic)
ISSN-L
0094-2405
Publication state
Published
Issued date
04/2024
Peer-reviewed
Oui
Volume
51
Number
4
Pages
3010-3019
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Studies comparing different radiotherapy treatment techniques-such as volumetric modulated arc therapy (VMAT) and helical tomotherapy (HT)-typically compare one treatment plan per technique. Often, some dose metrics favor one plan and others favor the other, so the final plan decision involves subjective preferences. Pareto front comparisons provide a more objective framework for comparing different treatment techniques. A Pareto front is the set of all treatment plans where improvement in one criterion is possible only by worsening another criterion. However, different Pareto fronts can be obtained depending on the chosen machine settings.
To compare VMAT and HT using Pareto fronts and blind expert evaluation, to explain the observed differences, and to illustrate limitations of using Pareto fronts.
We generated Pareto fronts for twenty-four prostate cancer patients treated at our clinic for VMAT and HT techniques using an in-house script that controlled a commercial treatment planning system. We varied the PTV under-coverage (100% - V <sub>95%</sub> ) and the rectum mean dose, and fixed the mean doses to the bladder and femoral heads. In order to ensure a fair comparison, those fixed mean doses were the same for the two treatment techniques and the sets of objective functions were chosen so that the conformity indexes of the two treatment techniques were also the same. We used the same machine settings as are used in our clinic. Then, we compared the VMAT and HT Pareto fronts using a specific metric (clinical distance measure) and validated the comparison using a blinded expert evaluation of treatment plans on these fronts for all patients in the cohort. Furthermore, we investigated the observed differences between VMAT and HT and pointed out limitations of using Pareto fronts.
Both clinical distance and blind treatment plan comparison showed that VMAT Pareto fronts were better than HT fronts. VMAT fronts for 10 and 6 MV beam energy were almost identical. HT fronts improved with different machine settings, but were still inferior to VMAT fronts.
That VMAT Pareto fronts are better than HT fronts may be explained by the fact that the linear accelerator can rapidly vary the dose rate. This is an advantage in simple geometries that might vanish in more complex geometries. Furthermore, one should be cautious when speaking about Pareto optimal plans as the best possible plans, as their calculation depends on many parameters.
To compare VMAT and HT using Pareto fronts and blind expert evaluation, to explain the observed differences, and to illustrate limitations of using Pareto fronts.
We generated Pareto fronts for twenty-four prostate cancer patients treated at our clinic for VMAT and HT techniques using an in-house script that controlled a commercial treatment planning system. We varied the PTV under-coverage (100% - V <sub>95%</sub> ) and the rectum mean dose, and fixed the mean doses to the bladder and femoral heads. In order to ensure a fair comparison, those fixed mean doses were the same for the two treatment techniques and the sets of objective functions were chosen so that the conformity indexes of the two treatment techniques were also the same. We used the same machine settings as are used in our clinic. Then, we compared the VMAT and HT Pareto fronts using a specific metric (clinical distance measure) and validated the comparison using a blinded expert evaluation of treatment plans on these fronts for all patients in the cohort. Furthermore, we investigated the observed differences between VMAT and HT and pointed out limitations of using Pareto fronts.
Both clinical distance and blind treatment plan comparison showed that VMAT Pareto fronts were better than HT fronts. VMAT fronts for 10 and 6 MV beam energy were almost identical. HT fronts improved with different machine settings, but were still inferior to VMAT fronts.
That VMAT Pareto fronts are better than HT fronts may be explained by the fact that the linear accelerator can rapidly vary the dose rate. This is an advantage in simple geometries that might vanish in more complex geometries. Furthermore, one should be cautious when speaking about Pareto optimal plans as the best possible plans, as their calculation depends on many parameters.
Keywords
Male, Humans, Radiotherapy, Intensity-Modulated/methods, Radiotherapy Planning, Computer-Assisted/methods, Radiotherapy Dosage, Prostatic Neoplasms/radiotherapy, Rectum, Organs at Risk, helical tomotherapy (HT), multi‐criteria optimization (MCO), pareto front, prostate, volumetric modulated arc therapy (VMAT)
Pubmed
Web of science
Open Access
Yes
Create date
07/12/2023 15:38
Last modification date
09/04/2024 6:14